Matthew Buten - Jan 5, 2025 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
Chief Financial Officer
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Jan 5, 2025
Transactions value $
-$98,957
Form type
4
Date filed
1/7/2025, 08:49 PM
Previous filing
Jan 4, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $0 +4.25K +2.22% $0.00 196K Jan 5, 2025 Direct F1
transaction BHVN Common Shares Tax liability -$99K -2.56K -1.31% $38.64 193K Jan 5, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to buy) Award $0 +104K $0.00 104K Jan 5, 2025 Common Shares 104K $38.64 Direct F3
transaction BHVN Restricted Share Unit Award Award $0 +17K $0.00 17K Jan 5, 2025 Common Shares 17K Direct F4, F5, F6
transaction BHVN Restricted Share Unit Award Options Exercise $0 -4.25K -25% $0.00 12.8K Jan 5, 2025 Common Shares 4.25K Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This balance includes 305 shares that were acquired through the Biohaven Employee Share Purchase Plan (the "ESPP") on May 31, 2023, 1,336 shares acquired through the ESPP on November 30, 2023, and 742 shares acquired through the ESPP on May 31, 2024.
F2 No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
F3 The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
F4 Each restricted share unit represents the contingent right to receive one common share of the Issuer.
F5 The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.
F6 Not applicable.